News and Announcements

GSK lifts annual guidance on strong virus treatment sales

By Frank Prenesti

Date: Wednesday 01 May 2024

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.
The company said it now expected a rise of 8% - 10% in annual adjusted earnings per share, up from the 6% - 9%...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page